✦ LIBER ✦

O1-05-01 The safety and efficacy of an extended-release formulation of galantamine (reminyl ER) in the treatment of Alzheimer's disease

✍ Scribed by Jody Corey-Bloom; Bing Yan; Michael Gold; Luc Truyen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of galantamine (Remi

✍ Alistair Burns; Roberto Bernabei; Roger Bullock; Alfonso J Cruz Jentoft; Lutz Fr 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 226 KB

(260) Efficacy and safety evaluation of

✍ N. Katz; S. Sun; L. Fox; F. Johnson; G. Wagner; J. Stauffer 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 44 KB

P1-347 An investigation into the safety,

✍ Joshua R. Shua-Haim; Mark D. Pass; Sameer Patel; Paul Lee; Pritesh Patel 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 164 KB

O2-05-08: A phase III study of the effic

✍ Paul Aisen; Serge Gauthier; Richard Briand; Daniel Saumier; Graziella Soulban; D 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Efficacy and safety of natural acetylcho

✍ Bai-song Wang; Hao Wang; Zhao-hui Wei; Yan-yan Song; Lu Zhang; Hong-zhuan Chen 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 452 KB

O1-03-01: The role of dietary supplement

✍ Patrick Massey 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 48 KB